Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 March 2007

Gender-specific comparison of five QT correction formulae in middle-aged participants in an atherosclerosis prevention program

Bernhard Strohmer, Christiana Christiana Schernthaner, Bernhard Paulweber, Maximilian Pichler

Med Sci Monit 2007; 13(4): CR165-171 :: ID: 481097

Abstract

  Background: Analysis of QT duration limited to a single heart rate correction formula might be problematic in cross-sectional studies. The aim of this study was to investigate five frequently used equations with respect to over- and under-correction of QT intervals in a middle-aged population without manifest atherosclerotic disease.
Material and Methods: A total of 1199 individuals (851 males, 348 females, aged 39 to 66 years) of the SAPHIR study (Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk) were investigated. Heart rate, RR, and QT intervals were measured automatically from resting ECGs with the 12SL™ ECG Analysis Program (GE Medical Systems). Five methods (Bazett, Fridericia, Framingham, Hodges, and Rautaharju) were used to correct the QT interval for heart rate.
Results: Females had shorter RR intervals than males (963±141 vs. 1022±158 ms, <i>p</i><0.0005), with longer QT (410±28 vs. 404±28 ms, <i>p</i>=0.003) and QTc intervals using all five formulae (<i>p</i><0.0005). No significant differences were observed between the gender groups for the QTc/RR slopes regardless of the formula. The Bazett formula performed the worst and the Fridericia the best in terms of rate adjustment success (slope B=–0.001). The optimal alpha of the best-fit equation (QTc=QT/RR<sup>&#945;</sup>) was calculated as 0.326 for males and 0.328 for females.
Conclusions: These results demonstrate that automatic QT measurements can be used reliably in cardiovascular prevention programs, encouraging further investigation of their clinical value in risk stratification. From an epidemiological perspective, however, the selected QT correction formula applied to a specific population has to be evaluated for appropriateness.

Keywords: Austria, Atherosclerosis - prevention & control, Electrocardiography - methods, Heart Rate - physiology, Regression Analysis, Sex Factors

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750